Literature DB >> 26771714

MMSET is dynamically regulated during cell-cycle progression and promotes normal DNA replication.

Debra L Evans1, Haoxing Zhang2,3, Hyoungjun Ham4, Huadong Pei2,5, SeungBaek Lee2, JungJin Kim2, Daniel D Billadeau2,4, Zhenkun Lou2.   

Abstract

The timely and precise duplication of cellular DNA is essential for maintaining genome integrity and is thus tightly-regulated. During mitosis and G1, the Origin Recognition Complex (ORC) binds to future replication origins, coordinating with multiple factors to load the minichromosome maintenance (MCM) complex onto future replication origins as part of the pre-replication complex (pre-RC). The pre-RC machinery, in turn, remains inactive until the subsequent S phase when it is required for replication fork formation, thereby initiating DNA replication. Multiple myeloma SET domain-containing protein (MMSET, a.k.a. WHSC1, NSD2) is a histone methyltransferase that is frequently overexpressed in aggressive cancers and is essential for normal human development. Several studies have suggested a role for MMSET in cell-cycle regulation; however, whether MMSET is itself regulated during cell-cycle progression has not been examined. In this study, we report that MMSET is degraded during S phase in a cullin-ring ligase 4-Cdt2 (CRL4(Cdt2)) and proteasome-dependent manner. Notably, we also report defects in DNA replication and a decreased association of pre-RC factors with chromatin in MMSET-depleted cells. Taken together, our results suggest a dynamic regulation of MMSET levels throughout the cell cycle, and further characterize the role of MMSET in DNA replication and cell-cycle progression.

Entities:  

Keywords:  Cdt2; DNA replication; E3 ubiquitin ligase; MMSET; cell cycle; proliferating cell nuclear antigen (PCNA); ubiquitin

Mesh:

Substances:

Year:  2016        PMID: 26771714      PMCID: PMC4825781          DOI: 10.1080/15384101.2015.1121323

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  64 in total

1.  CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation.

Authors:  Hideo Nishitani; Yasushi Shiomi; Hiroka Iida; Masato Michishita; Toshihiro Takami; Toshiki Tsurimoto
Journal:  J Biol Chem       Date:  2008-08-14       Impact factor: 5.157

Review 2.  The etiology of Wolf-Hirschhorn syndrome.

Authors:  Andrew D Bergemann; Francesca Cole; Kurt Hirschhorn
Journal:  Trends Genet       Date:  2005-03       Impact factor: 11.639

3.  CRL4(Cdt2)-mediated destruction of the histone methyltransferase Set8 prevents premature chromatin compaction in S phase.

Authors:  Richard C Centore; Courtney G Havens; Amity L Manning; Ju-Mei Li; Rachel Litman Flynn; Alice Tse; Jianping Jin; Nicholas J Dyson; Johannes C Walter; Lee Zou
Journal:  Mol Cell       Date:  2010-10-08       Impact factor: 17.970

4.  Activation of the MCM2-7 helicase by association with Cdc45 and GINS proteins.

Authors:  Ivar Ilves; Tatjana Petojevic; James J Pesavento; Michael R Botchan
Journal:  Mol Cell       Date:  2010-01-29       Impact factor: 17.970

5.  HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by Geminin.

Authors:  Benoit Miotto; Kevin Struhl
Journal:  Mol Cell       Date:  2010-01-15       Impact factor: 17.970

6.  MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.

Authors:  Jose L R Brito; Brian Walker; Matthew Jenner; Nicholas J Dickens; Nicola J M Brown; Fiona M Ross; Athanasia Avramidou; Julie A E Irving; David Gonzalez; Faith E Davies; Gareth J Morgan
Journal:  Haematologica       Date:  2008-12-04       Impact factor: 9.941

7.  The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.

Authors:  Youngjo Kim; Natalia G Starostina; Edward T Kipreos
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

8.  A histone H3 lysine 36 trimethyltransferase links Nkx2-5 to Wolf-Hirschhorn syndrome.

Authors:  Keisuke Nimura; Kiyoe Ura; Hidetaka Shiratori; Masato Ikawa; Masaru Okabe; Robert J Schwartz; Yasufumi Kaneda
Journal:  Nature       Date:  2009-05-31       Impact factor: 49.962

9.  MMSET is overexpressed in cancers: link with tumor aggressiveness.

Authors:  Alboukadel Kassambara; Bernard Klein; Jérome Moreaux
Journal:  Biochem Biophys Res Commun       Date:  2008-12-31       Impact factor: 3.575

10.  Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17.

Authors:  Min Deng; Fahui Li; Bryan A Ballif; Shan Li; Xi Chen; Lin Guo; Xin Ye
Journal:  J Biol Chem       Date:  2009-01-16       Impact factor: 5.157

View more
  9 in total

1.  AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.

Authors:  Ni Li; Wei Xue; Huairui Yuan; Baijun Dong; Yufeng Ding; Yongfeng Liu; Min Jiang; Shan Kan; Tongyu Sun; Jiale Ren; Qiang Pan; Xiang Li; Peiyuan Zhang; Guohong Hu; Yan Wang; Xiaoming Wang; Qintong Li; Jun Qin
Journal:  J Clin Invest       Date:  2017-03-20       Impact factor: 14.808

2.  Wolf-Hirschhorn Syndrome Candidate 1 Is Necessary for Correct Hematopoietic and B Cell Development.

Authors:  Elena Campos-Sanchez; Nerea Deleyto-Seldas; Veronica Dominguez; Enrique Carrillo-de-Santa-Pau; Kiyoe Ura; Pedro P Rocha; JungHyun Kim; Arafat Aljoufi; Anna Esteve-Codina; Marc Dabad; Marta Gut; Holger Heyn; Yasufumi Kaneda; Keisuke Nimura; Jane A Skok; Maria Luisa Martinez-Frias; Cesar Cobaleda
Journal:  Cell Rep       Date:  2017-05-23       Impact factor: 9.423

Review 3.  Chromatin-Bound Cullin-Ring Ligases: Regulatory Roles in DNA Replication and Potential Targeting for Cancer Therapy.

Authors:  Sang-Min Jang; Christophe E Redon; Mirit I Aladjem
Journal:  Front Mol Biosci       Date:  2018-03-13

4.  The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.

Authors:  Hiroshi Tanaka; Tomoka Igata; Kan Etoh; Tomoaki Koga; Shin-Ichiro Takebayashi; Mitsuyoshi Nakao
Journal:  Aging Cell       Date:  2020-06-22       Impact factor: 9.304

Review 5.  Genome Instability in Multiple Myeloma: Facts and Factors.

Authors:  Anna Y Aksenova; Anna S Zhuk; Artem G Lada; Irina V Zotova; Elena I Stepchenkova; Ivan I Kostroma; Sergey V Gritsaev; Youri I Pavlov
Journal:  Cancers (Basel)       Date:  2021-11-26       Impact factor: 6.639

6.  Role of DTL in Hepatocellular Carcinoma and Its Impact on the Tumor Microenvironment.

Authors:  Zuyin Li; Rangrang Wang; Chen Qiu; Can Cao; Jianming Zhang; Jun Ge; Yuanping Shi
Journal:  Front Immunol       Date:  2022-03-22       Impact factor: 7.561

Review 7.  The emerging role for Cullin 4 family of E3 ligases in tumorigenesis.

Authors:  Ji Cheng; Jianping Guo; Brian J North; Kaixiong Tao; Pengbo Zhou; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2018-12-30       Impact factor: 10.680

8.  MB4-2/MB4-3 transcripts of IGH-MMSET fusion gene in t(4;14)pos multiple myeloma indicate poor prognosis.

Authors:  Feng Li; Yong-Ping Zhai; Ting Lai; Qian Zhao; Hui Zhang; Yu-Mei Tang; Jian Hou
Journal:  Oncotarget       Date:  2017-05-24

Review 9.  Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases.

Authors:  Sang-Min Jang; Christophe E Redon; Bhushan L Thakur; Meriam K Bahta; Mirit I Aladjem
Journal:  Exp Mol Med       Date:  2020-10-02       Impact factor: 8.718

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.